
Marissa Jill Perman MD
Pediatric Dermatology
Associate Professor, Clinical Pediatrics and Dermatology, Perelman School of Medicine and Children's Hospital of Philadelphia
Join to View Full Profile
3500 Civic Center Blvd FL 6Philadelphia, PA 19104
Phone+1 215-590-2169
Fax+1 215-590-4948
Dr. Perman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Dermatology, 2008 - 2011
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2005 - 2008
University of Maryland School of MedicineClass of 2005
ChildrenFellowship, Pediatric Dermatology
Certifications & Licensure
PA State Medical License 2011 - 2026
OH State Medical License 2005 - 2012
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology
Publications & Presentations
PubMed
- 1 citationsFunctional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa.Pirunthan Pathmarajah, Edward Eid, Jaron Nazaroff, Jodi So, Vaishali Mittal
The British Journal of Dermatology. 2025-04-28 - Infantile Hemangioma With Aggressive, Early-Onset Ulceration, and Kasabach-Merritt-Like Phenomenon in a Newborn.Charles Y Huang, María Trinidad Hasbún, Robert F Duffy, Robert J Smith, Ngan Do
Pediatric Dermatology. 2024-12-27 - 1 citationsRapidly Progressive Idiopathic Pyoderma Gangrenosum in a Pediatric Patient Successfully Treated With Infliximab.Nikhita J Perry, Stephanie Wang, Robert Smith, Robert Duffy, Maria Queenan
Pediatric Dermatology. 2024-11-25
Press Mentions
FDA Approves Zevaskyn for Treating RDEB-Related Blistering WoundsMay 4th, 2025
Breakthrough Gene Therapy for Butterfly Children’s DiseaseApril 30th, 2025
Dupilumab’s Versatility Shown in off-Label UsesAugust 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









